Eurofins to conduct U.K. genotyping research program

By LabPulse.com staff writers

March 11, 2022 -- Eurofins Genomics will genotype 5 million consenting participants in support of the Our Future Health program, a genotyping research program in the U.K.

As part of the effort, Eurofins will establish a dedicated laboratory in the U.K. where it will carry out genotyping to identify genetic variations and combinations.

The company said that the undertaking will provide important data that, when combined with other questionnaires and health information, will generate a comprehensive picture of population health in the U.K.

Eurofins added that the insights will be used to transform the prevention, detection, and treatment of diseases.

Eurofins will utilize specifically designed microarray technology to identify hundreds of thousands of genetic variations at a time. The resulting data will then be used to determine disease risks and discover biomarkers for disease diagnosis and therapeutics, the company said.

Our Future Health program facilitates the discovery and development of new methods of prevention, early detection, and treatment of a wide range of diseases.

Eurofins subsidiary launches at-home test for 'forever chemicals'
Eurofins Scientific subsidiary EmpowerDX has launched a new at-home blood test to detect and measure more than 40 per- and polyfluorinated alkyl substances...
Eurofins unit partners with Gingko on COVID-19 testing
Eurofins Scientific subsidiary Clinical Enterprise and Ginkgo Bioworks have formed a partnership to support a federally funded COVID-19 polymerase chain...
Eurofins launches assay to detect omicron variant of COVID
Eurofins Technologies has launched a multiplex reverse transcription polymerase chain reaction assay that can detect the omicron variant of COVID-19.
Eurofins debuts 2 combined tests for COVID/influenza, RSV
Eurofins Technologies has launched two new reverse transcription polymerase chain reaction tests for the simultaneous detection of SARS-CoV-2, influenza...
Eurofins lands $30M COVID diagnostic testing contract
Eurofins Genomics has won a $30 million contract with the U.S. Department of Air Force and the U.S. Department of Health and Human Services to build...

Copyright © 2022 LabPulse.com

Last Updated ls 3/11/2022 8:40:28 AM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current